Findings suggest the coronavirus vaccine remains remarkably effective outside a controlled trial setting

Pfizer-BioNTech's Covid-19 vaccine appears to reduce symptomatic coronavirus infections by more than 90% in the real world, Israeli researchers said Sunday.